Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...

A new investigative report released by Senators Kirsten Gillibrand (D-NY) and Rick Scott (R-FL), ranking member and chairman of the US Senate Special Committee on Aging, respectively, details the ...

Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...

Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. No matter how great a title's gameplay may be, there's always the ...

Dr. Reddy’s Laboratories (NYSE:RDY) is preparing to launch a generic version of semaglutide, the active ingredient in Novo Nordisk’s (NVO) weight loss drug Wegovy, in 87 countries beginning in 2026, ...

July 11 (Reuters) - Novartis (NOVN.S), opens new tab cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug Entresto before its patent ...

On April 2, President Donald Trump announced a 10% tariff on imports from all countries, effective on April 5. As for the generics industry, pharmaceuticals were among the exemptions listed in the ...

SHANGHAI, Feb 9 (Reuters) - China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through the country's public hospitals, saying an ...

The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country. The agency said it ...